HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

G280-9V peptide

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Amino Acids, Peptides, and Proteins: 1
- Proteins: 484843
  - Membrane Proteins: 10078
    - gp100 Melanoma Antigen: 32
      - G280-9V peptide: 1
  - Neoplasm Proteins: 2
    - Melanoma-Specific Antigens: 223
      - gp100 Melanoma Antigen: 32
        G280-9V peptide: 1
- Peptides: 82426
  - G280-9V peptide: 1
Biological Factors: 2472
- Antigens: 143924
  - Neoplasm Antigens: 6217
    - Melanoma-Specific Antigens: 223
      - gp100 Melanoma Antigen: 32
        G280-9V peptide: 1

Experts

1.	Cheung, Amy M: 1 article (11/2005)
2.	Daley, Heather: 1 article (11/2005)
3.	Eapen, Sara G: 1 article (11/2005)
4.	Fee, Sharon V: 1 article (11/2005)
5.	Haluska, Frank G: 1 article (11/2005)
6.	Hodi, F Stephen: 1 article (11/2005)
7.	Jonasch, Eric P: 1 article (11/2005)
8.	Linette, Gerald P: 1 article (11/2005)
9.	Longerich, Simonne: 1 article (11/2005)
10.	Rubin, Krista M: 1 article (11/2005)

Related Diseases

1.

Melanoma (Melanoma, Malignant)

11/01/2005 - "Twelve HLA-A*0201(+) patients with advanced melanoma were administered dendritic cells pulsed with G280-9V peptide. "
11/01/2005 - "To determine the toxicity, maximal tolerated dose, and clinical and immunologic response to autologous dendritic cells pulsed with melanoma-associated antigen gp100-derived G280-9V peptide. "
11/01/2005 - "Immunization using autologous dendritic cells pulsed with the melanoma-associated antigen gp100-derived G280-9V peptide elicits CD8+ immunity."
11/01/2005 - "The high rate of immunization as measured by three independent assays and the occurrence of clinical regression support continued investigation of G280-9V peptide as a candidate epitope in melanoma vaccine formulations."

Related Drugs and Biologics

1.	Vaccines
2.	Antigens
3.	Epitopes
4.	HLA-A*02:01 antigen